dihydroxyphenylalanine has been researched along with Charcot-Marie-Tooth Disease in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Charcot-Marie-Tooth Disease: A hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dupuis, JM | 1 |
| Brucher, JM | 1 |
| Tranchant, C | 1 |
| Ruh, D | 1 |
| Warter, JM | 1 |
1 review available for dihydroxyphenylalanine and Charcot-Marie-Tooth Disease
| Article | Year |
|---|---|
[Type II Charcot-Marie-Tooth and dopa-sensitive Parkinson disease].
Topics: Charcot-Marie-Tooth Disease; Dihydroxyphenylalanine; Humans; Male; Middle Aged; Parkinson Disease, S | 1994 |
1 other study available for dihydroxyphenylalanine and Charcot-Marie-Tooth Disease
| Article | Year |
|---|---|
[Charcot-Marie-Tooth disease type II and dopa-sensitive Parkinson syndrome].
Topics: Aged; Charcot-Marie-Tooth Disease; Dihydroxyphenylalanine; Humans; Male; Parkinson Disease | 1994 |